Ortin Global Second Quarter 2025 Earnings: ₹58.00 loss per share (vs ₹1.38 loss in 2Q 2024)
Ortin Global (NSE:ORTINGLOBE) Second Quarter 2025 Results
Key Financial Results
- Revenue: ₹525.0k (down 80% from 2Q 2024).
- Net loss: ₹4.72m (loss narrowed by 58% from 2Q 2024).
- ₹58.00 loss per share.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Ortin Global shares are down 7.2% from a week ago.
Risk Analysis
Be aware that Ortin Global is showing 5 warning signs in our investment analysis and 4 of those are potentially serious...
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:ORTINGLOBE
Ortin Global
Engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India.
Moderate with adequate balance sheet.
